Quick Answer
Tenaya Therapeutics, Inc. reported Shares Outstanding of 216.76 million shares for fiscal year 2025.
Tenaya Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 216.76M | +150.5% |
| 2024 | 86.54M | +26.7% |
| 2023 | 68.33M | +2.2% |
| 2022 | 66.86M | +61.9% |
| 2021 | 41.29M | +3311.6% |
| 2020 | 1.21M | — |
- Tenaya Therapeutics, Inc. showed an increase of +150.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Tenaya Therapeutics, Inc.’s shares outstanding has grown by 17809.5% (from 1.21 million shares to 216.76 million shares).
- The most recent figure is from Tenaya Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: